Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.9M Buy
402,000
+200,000
+99% +$36.2M 0.25% 85
2026
Q1
$29.7M Sell
202,000
-126,000
-38% -$20.5M 0.19% 103
2025
Q4
$63.9M Buy
328,000
+323,500
+7,189% +$77M 0.4% 61
2025
Q3
$1.27M Buy
+4,500
New +$1.15M 0.01% 319

Other funds holding ORCL

Marex Group's ORCL Position: Q2 2026 in Review

Marex Group reduced its Oracle (ORCL) stake by 20% in Q2 2026, selling an estimated $27.8M and leaving 596,634 shares worth $87.4M. The position accounts for 0.37% of the portfolio, ranked #64.

Marex Group first reported a position in ORCL in Q4 2022 and has held it in 12 quarters since. The position peaked at $192M in Q4 2025. 3,537 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Marex Group held 596,634 shares of Oracle worth $87.4M as of Q2 2026.
  • Marex Group sold 153,253 Oracle shares in Q2 2026, an estimated $27.8M.
  • Oracle made up 0.37% of Marex Group's portfolio in Q2 2026, its #64 holding.
  • Marex Group first reported a position in Oracle in Q4 2022 and has held it in 12 quarters since.
  • Marex Group's Oracle position peaked at $192M in Q4 2025.
  • 3,537 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.